BIIB: Biogen Inc. Stock

by  •  • Comments Off on BIIB: Biogen Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 23,025.11
Enterprise Value ($M) 27,619.81
Book Value ($M) 16,358.90
Book Value / Share 112.26
Price / Book 1.41
NCAV ($M) -5,123.80
NCAV / Share -35.16
Price / NCAV -4.49

Profitability (mra)
Return on Invested Capital (ROIC) 0.07
Return on Assets (ROA) 0.06
Return on Equity (ROE) 0.11

Liquidity (mrq)
Quick Ratio 0.80
Current Ratio 1.26

Balance Sheet (mrq) ($M)
Current Assets 6,830.50
Assets 28,313.20
Liabilities 11,954.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-12 13G/A Vanguard Group Inc 11.44 0.00
10-16 13G State Street Corp 5.00
08-07 13G/A BlackRock, Inc. 10.10 2.81
02-12 13G/A Primecap Management Co/ca/ 11.22 3.59

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-24 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-02-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 125,184 1,269,584 9.86
2024-11-21 160,613 1,556,580 10.32
2024-11-20 152,159 1,320,313 11.52
2024-11-19 144,104 988,683 14.58
2024-11-18 244,295 1,331,151 18.35

(click for more detail)

Similar Companies
BCRX – BioCryst Pharmaceuticals, Inc. BDTX – Black Diamond Therapeutics, Inc.
BEAM – Beam Therapeutics Inc. BLUE – bluebird bio, Inc.
BMEA – Biomea Fusion, Inc.


Financial data and stock pages provided by
Fintel.io